Early tumor diagnosis

TCR sequences of the tumor are not entirely random and may be related to the pathogenesis of tumor. Combining high-throughput sequencing and bioinformatics analysis, we analyze the clonality and proportion of TCR sequences to accurately monitor anti-tumor immune responses and to make early diagnosis.
By analyzing the diversity of TCR repertoire, we can monitor the course of T cell lymphoma. We do deep sequencing for TCR repertoire to provide basis for diagnosis of T cell leukemia.


Los Angeles California

Address:  5370 Alhambra Ave Ste F, Los Angeles, CA 90032, USA


Durham North Carolina

Address: 701 West Main St. Suite 200, Durham 27701 USA



Thank you for coming to TCRCure, if you have the intention of cooperation, please leave us a message or use the following ways to contact us, and to provide you with the most sincere professional services, thank you.


© 2017 Chongqing TCRCure Biological Technology Co Ltd. All Rights Reserved.  渝ICP备17005995号  Powered by: www.300.cnManager